NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS - SERUM APOLIPOPROTEIN LEVELS AND CHOLESTEROL-METABOLISM IN MONOCYTE-DERIVED MACROPHAGES

被引:8
作者
BERGMAN, R
AVIRAM, M
BITTERMANDEUTSCH, O
OIKNINE, Y
SHEMER, A
SREBNIK, A
BROOK, JG
FRIEDMANBIRNBAUM, R
机构
[1] TECHNION ISRAEL INST TECHNOL,FAC MED,IL-31096 HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,HAIFA,ISRAEL
[3] ICHILOV HOSP,TEL AVIV MED CTR,DEPT DERMATOL,IL-64239 TEL AVIV,ISRAEL
关键词
D O I
10.1007/BF01800597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neutral lipid storage disease with ichthyosis (NLSDI) is an inherited metabolic disorder characterized by accumulation of neutral lipids, in a wide variety of cells, by a still unknown mechanism. Previous studies have shown normal cholesterol content in NLSDI granulocytes, fibroblasts and skin cells. Monocyte-derived macrophages possess an additional pathway of cholesterol uptake, which is not shared by these cells and which is not regulated by intracellular cholesterol levels. This pathway is thought to play a role in the process of atherosclerosis. Three NLSDI patients were studied. The serum levels of triglycerides, cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A-I and B were within normal limits in all three patients. The intracellular levels of free and esterified cholesterol were measured in the monocyte-derived macrophages of one patient and found to be normal, while the triglyceride concentrations were twice as high as normal. The cholesterol esterification rates, which serve as a sensitive indicator of intracellular changes in cholesteryl ester levels, were normal in the monocyte-derived macrophages of all three patients. These findings provide further evidence that cholesterol metabolism is not disturbed in NLSDI, and it may be inferred that in this respect these patients are not at increased risk for atherosclerosis.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 21 条
  • [1] ALAUPOVIC D, 1978, INT C ATHEROSCLEROSI, P109
  • [2] MULTISYSTEM TRIGLYCERIDE STORAGE DISORDER WITH IMPAIRED LONG-CHAIN FATTY-ACID OXIDATION
    ANGELINI, C
    PHILIPPART, M
    BORRONE, C
    BRESOLIN, N
    CANTINI, M
    LUCKE, S
    [J]. ANNALS OF NEUROLOGY, 1980, 7 (01) : 5 - 10
  • [3] LOW-DENSITY LIPOPROTEIN AND SCAVENGER RECEPTOR ACTIVITIES ARE MODULATED BY SECRETORY PRODUCTS DERIVED FROM CELLS OF THE ARTERIAL-WALL
    AVIRAM, M
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (05): : 445 - 449
  • [4] AVIRAM M, 1989, J CLIN CHEM CLIN BIO, V27, P3
  • [5] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [6] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1986, 232 (4746) : 34 - 47
  • [7] BROWN MS, 1980, J BIOL CHEM, V255, P9344
  • [8] LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 : 223 - 261
  • [9] NEUTRAL LIPID STORAGE DISEASE - NEW DISORDER OF LIPID-METABOLISM
    CHANARIN, I
    PATEL, A
    SLAVIN, G
    WILLS, EJ
    ANDREWS, TM
    STEWART, G
    [J]. BRITISH MEDICAL JOURNAL, 1975, 1 (5957) : 553 - 555
  • [10] CHIAMORI N, 1959, AM J CLIN PATHOL, V31, P305